INTRODUCTION
============

Phosphatidylinositol (PI) is a versatile lipid that not only serves as a structural component of cellular membranes, but also plays important roles in signal transduction through distinct phosphorylated derivatives of the inositol head group ([@B16]). The pathway for de novo synthesis of PI begins with the acylation of glycerol 3-phosphate (G3P) at the *sn*-1 position by G3P acyltransferase to form lysophosphatidic acid (lysoPA). LysoPA is further acylated at the *sn*-2 position by lysoPA acyltransferase to form phosphatidic acid (PA), which serves as a general precursor for all phospholipids ([@B17]; [@B58]). PA is then converted to cytidinediphosphodiacylglycerol (CDP-DAG), which combines with inositol to form PI. The newly synthesized PI possesses a mono- or di-unsaturated fatty acid at the *sn*-2 position ([@B2]; [@B24], [@B26]). In contrast, three-fourths or more of membrane PI obtained from mammalian tissues are constituted by the 1-stearoyl-2-arachidonoyl (18:0/20:4) species ([@B25]; [@B3]). Considerable attention has been paid to how membrane PI retains such a high proportion of arachidonoyl molecular species at the *sn*-2 position. It has been widely accepted that arachidonic acid (AA) is incorporated into PI by fatty acid remodeling in which the *sn*-2 acyl chain is replaced with AA by the sequential actions of phospholipase A~2~ (PLA~2~) and lysoPI acyltransferase (LPIAT) after de novo synthesis of PI ([@B2]; [@B24], [@B26]; [@B37]). In an RNA interference (RNAi)-based genetic screen, we recently identified *mboa-7*/LPIAT, a member of the membrane-bound *O*-acyltransferases (MBOAT) family, as an acyltransferase that selectively incorporates polyunsaturated fatty acids (PUFAs), such as AA and eicosapentaenoic acid (EPA), into the *sn-*2 position of PI ([@B36]). In this screen, we used the model organism *Caenorhabditis elegans* in which 1-stearoyl-2-eicosapentaenoyl (18:0/20:5) PI is the major PI species (Supplementary Figure 1; [@B36]). In *C. elegans mboa-7*/LPIAT mutants, EPA attached at the *sn-*2 position of PI was remarkably reduced and was replaced with other fatty acids such as oleic acid (18:1), indicating that fatty acid remodeling is crucial for determining the mature PI species.

On the other hand, many lines of evidence suggest that fatty acid remodeling also occurs at the *sn-*1 position of PI. In experiments with rabbit alveolar macrophage microsomes, newly synthesized PI from \[^14^C\]G3P contains palmitic acid (16:0), oleic acid (18:1), and linoleic acid (18:2) at the *sn-*1 position, but very low levels of stearic acid (18:0), the predominant fatty acid esterified at the *sn-*1 position of tissue PI ([@B45]). In addition, incubation of rat liver microsomes with dipalmitoyl (16:0/16:0) CDP-DAG and \[^3^H\]inositol results in the rapid synthesis of \[^3^H\]PI and \[^3^H\]lysoPI, the latter of which is subsequently reacylated with stearic acid (18:0) at the *sn-*1 position ([@B13],[@B14]). This suggests that dipalmitoyl \[^3^H\]PI formed by the microsomes is rapidly hydrolyzed by phospholipase A~1~ (PLA~1~) to produce *sn*-2-acyl lysoPI, which is then reacylated with stearic acid by acyltransferase, which is present in the microsomes. In fact, a high level of stearoyl-CoA:*sn*-2-acyl lysoPI acyltransferase activity was detected in rat liver microsomes ([@B27]; [@B15]). These data strongly suggest that the fatty acid composition at the *sn-*1 position of PI is determined by the sequential actions of PLA~1~ and acyltransferase. However, the genes involved in this process have not been identified.

We previously showed that *ipla-1*, an intracellular PLA~1~ family member ([@B29]), acts as a regulator of asymmetric cell divisions in *C. elegans* ([@B31]). Loss of *ipla-1* causes defects in asymmetric cell-fate determination and orientation of division of stem cell-like epithelial cells, called seam cells. We also found that a mutation of *tbc-3* or *mon-2*, both of which are thought to be involved in endosome-to-Golgi retrograde transport ([@B32]; [@B20]), suppresses the seam cell phenotypes of *ipla-1* mutants. However, the role of *ipla-1* in phospholipid fatty acid metabolism has not been determined. In this work, we analyzed the phospholipid fatty acid composition of *ipla-1* mutants and found that the *sn-*1 fatty acid composition of PI was significantly altered in the mutants. Furthermore, we identified evolutionarily conserved acyltransferases that are required for normal fatty acid composition of the *sn-*1 acyl moiety of PI.

MATERIALS AND METHODS
=====================

Materials
---------

PI and lysoPI from bovine liver,lysoPC from egg yolk, dioleoyl PA, dioleoyl phosphatidylcholine (PC), dioleoyl PE, 1-palmitoyl-2-oleoyl phosphatidylserine (PS) were purchased from Avanti Polar Lipids (Alabaster, AL). Phosphatidylglycerol (PG) from egg yolk was purchased from Sigma-Aldrich (St. Louis, MO). Dipalmitoyl PI was purchased from Serdary Research Laboratories (London, ON, Canada). \[1-^14^C\]palmitoyl-CoA, \[1-^14^C\]stearoyl-CoA, \[1-^14^C\]oleoyl-CoA, and \[1-^14^C\]arachidonoyl-CoA were purchased from American Radiolabeled Chemicals (St. Louis, MO). *Rhizopus delemer* lipase was purchased from Seikagaku (Tokyo, Japan). PLA~2~ from honey bee venom was purchased from Sigma-Aldrich.

General Methods and Strains
---------------------------

Worm cultures, genetic crosses, and other *C. elegans* methods were performed according to standard protocols ([@B9]) except where otherwise indicated. The following mutations and transgenes were used: *ipla-1(xh13)*, *acl-8 acl-9(tm2290)*, *acl-10(tm1045)*, *mon-2(xh22)*, *tbc-3(xh23)*, *acs-20(tm3232*)*; acs-22(tm3236*) ([@B30]), *wIs51\[scm::gfp\], osIs10\[scm::wrm-1::venus\], xhEx3517\[acl-10p::gfp; rol-6(su1006)\], xhEx3518\[acl-10p::acl-10::gfp; rol-6(su1006)\], xhEx3523\[acl-10p::acl-10::gfp, dpy-7p::ipla-1::mCherry\], xhEx3526\[dpy- 7p::ipla-1::mCherry\], xhEx3529\[acl-10p::acl-10::mCherry\], tmEx1920\[acs-20p:: acs-20::egfp, gcy-10p::DsRed\]* ([@B30]), *xhEx3514\[scm::acl-10; Pges-1::dsREDm\], xhEx3521\[dpy-7p::mouse LYCAT; Pges-1::dsREDm\], xhIs3501\[dpy-7p::acl-10; Pges-1::dsREDm\]*. The mutant alleles *acl-8 acl-9(tm2290)* and *acl-10(tm1045*) were isolated in this study by TMP (trimethylpsoralen)/UV method ([@B18]). The following primers for *acl-8 acl-9* deletion screen were used: 5′-CGA CTG TGC TTC TCG ACT AA-3′; 5′-TAG TGC GGA AGA GAA CTT GT-3′; 5′-TCC TCA CTT CTC GGA ACT GT-3′; and 5′-AGG CAC CTC ATA GTG GTT GC-3′, and the following primers for *acl-10* deletion screen were used: 5′-TCG AGG AGG AAA CAC CTT CT-3′; 5′-CTA CTT GCA TCC TGC TCG TT-3′; 5′-CGT CCA TTA CTC GGA TGG TT-3′; and 5′-AAT GGA CTT CTC GTG GAC TT-3′. Some of the strains used in this work were obtained from *Caenorhabditis* Genetics Center (University of Minnesota, Minneapolis, MN). All mutations and were backcrossed at least five times before further analysis.

Cloning of C. elegans acl-10 and Mouse LYCAT
--------------------------------------------

*acl-10* cDNA (GenBank accession number [NM_073570](NM_073570)) was amplified by PCR from a *C. elegans* cDNA library using the primers, 5′-CAG AAG CTA GCA TGA TGA GGA TTC CAT GTC-3′ and 5′-AAA ATG GTA CCT TAT ATA GAA GAA GAT GAT-3′, and were cloned into pPD49.78 (a gift from Dr. A. Fire, Stanford University) at the NheI and KpnI sites. Mouse LYCAT cDNA (GenBank accession number [NM_001081071](NM_001081071)) was amplified from a cDNA library derived from mouse heart using the primers, 5′-CCC GGG TAC CGA ATT CAC CAT GGA GCA GAA GCT GA-3′ and 5′-GGC CAT CGA TCT CGA GTT ACT CAT TTT TCT TTG AAT-3′, and cloned into pCAGGS-MCS vector (N-terminal Myc tag) at the *Eco*RI and *Xho*I sites.

Constructs and Transgenic Worms
-------------------------------

For each construct, more than three independent transgenic lines were analyzed. pIR1 (*acl-10p::gfp*), pIR2 (*acl-10p::acl-10::gfp*), pIR3 (*dpy-7p::acl-10*), pIR4 (*scm::acl-10*), pIR5 (*dpy-7p::ipla-1::mCherry*), pIR6 (*acl-10p::acl-10::mCherry*) and pIR7 (*dpy-7p::mouse LYCAT*) were prepared as follows. pIR1 (*acl-10p::gfp*): 0.6-kb genomic fragment immediately upstream the ATG initiation codon of *acl-10* was PCR amplified using the primers 5′-AAA TGC TGC AGA ATC GGA TAA AGA AAG GTG-3′ and 5′-GGA ATG GAT CCC ATT TCA ACT TCT GGA TGT G-3′, and cloned into pPD95.67 (NLS-; a derivative of pPD95.67, a gift from A. Fire, Stanford University School of Medicine) at the PstI and BamHI sites. pPD95.67 (NLS-) was constructed by removal of nuclear localization signal (NLS) from pPD95.67. pIR2 (*acl-10p::acl-10::gfp*): 3.3-kb genomic fragment corresponding to 0.6 kb immediately upstream the ATG initiation codon of *acl-10* and the full-length *acl-10* (2.7 kb) was PCR amplified using the primers 5′-AAA TGC TGC AGA ATC GGA TAA AGA AAG GTG-3′ and 5′-CCC GGG GAT CCG CTA TAG AAG AAG ATG ATG GC-3′, and cloned into pPD95.67 (NLS-) at the PstI and BamHI sites. pIR3 (*dpy-7p::acl-10*): *acl-10* cDNA was subcloned under a *dpy-7* promoter in a pTK030 ([@B31]) at the SmaI and NotI sites. pIR4 (*scm::acl-10*): *acl-10* cDNA was subcloned under a *scm* promoter in a pTK020 ([@B31]) at the SmaI and NotI sites. pIR5 (*dpy-7p::ipla-1::mCherry*): *dpy-7p::ipla-1* was PCR amplified from pTK030 ([@B31]) and was cloned into *unc-122p::arl-8::mCherry* (pYB109; [@B44]) at the BamHI and NotI sites. pIR6 (*acl-10p::acl-10::mCherry*): *acl-10p::acl-10* (described above) was PCR amplified using the primers 5′-AAA TGG GAT CCA ATC GGA TAA AGA AAG GTG-3′ and 5′-GCC AAT CCC GGC GGC CGC CTA CCG GTA CCC TCC AAG GGT CCT CCT TTG GGT CCT TTG GCC AAT CCC GGG GGT CGG CTA TAG AAG AAG ATG ATG GCG-3′, and was cloned into pYB109 ([@B44]) at the BamHI and NotI sites. pIR7 (*dpy-7p::mouse LYCAT*): Mouse LYCAT cDNA was PCR amplified using the primers 5′-GGG ATG GTC TCC TGG AAG GGA-3′ and 5′-AGA ATA GGG CGC GGC CGC TTA CTC ATT TTT CTT TG-3′, and cloned under a *dpy-7* promoter in a pTK030 at the SmaI and NotI sites. The primers used were designed based on the codon-usage preference in *C. elegans* ([@B53]).

Lipid Analysis
--------------

Total lipids of synchronized L4 stage worms were extracted by the method of Bligh and Dyer ([@B8]). The fatty acid composition of each phospholipid was determined by gas chromatography (GC) as described previously ([@B36]) with slight modifications. Briefly, phospholipids were separated from total lipids by one-dimensional TLC on silica gel 60 plates (Merck Biosciences, Darmstadt, Germany) in chloroform:methanol:acetic acid (65:25:13, vol/vol). The area of silica gel corresponding to each phospholipid (PC, PE, and PS+PI) was scraped off the plates. The PS+PI fraction was reextracted and separated by TLC in chloroform:ethanol:water:triethylamine (30:35:7:35, vol/vol), and the areas of silica gel corresponding to PS and PI were scraped off the plates. Each phospholipid fraction was then treated with dehydrated methanol:acetyl chloride (10:1) to produce the fatty acid methyl esters. The fatty acid methyl ester derivatives were further analyzed with a GC 353B gas chromatograph equipped with a flame ionization detector (GL Sciences, Tokyo, Japan). Liquid chromatography/electrospray ionization-mass spectrometry (LC/ESI-MS) analysis was performed as described previously ([@B5]) using 1,2-dipalmitoyl PI as internal standard.

PLA Assay
---------

PLA assay using recombinant IPLA-1 was performed as described previously ([@B41]), except that human embryonic kidney (HEK) 293 cells were used instead of HeLa cells. Purified recombinant protein was incubated with liposomes containing each phospholipid (dioleoyl PA, dioleoyl PC, dioleoyl PE, 1-palmitoyl-2-oleoyl PS, and dipalmitoyl PI) at 37°C for 3 h. The released free fatty acid level was measured with the ACS-ACOD method (NEFA C-Test kit 279--75401, Wako Chemical, Osaka, Japan).

Acyltransferase Assay
---------------------

*sn*-2-acyl-1-lysophospholipids (*sn*-2-acyl lysophospholipids) were prepared as described previously ([@B36]) using dioleoyl PC, dioleoyl PE, *sn*-1-palmitoyl-2-oleoyl PS, bovine liver PI, and egg yolk PG. Each *sn*-2-acyl lysophospholipid was immediately used for acyltransferase assay. Because *sn*-2-acyl lysophospholipid is known to easily isomerize to *sn*-1-acyl-2-lysophospholipid (*sn*-1-acyl lysophospholipid), it is possible that ^14^C-acyl donor is incorporated into *sn*-1-acyl lysophospholipid and *sn*-2-acyl lysophospholipid (Supplementary Figure 2A). Thus, an accurate measure of *sn*-2-acyl lysophospholipid acyltransferase activity could only be obtained by determining the position that had been acylated. The acyltransferase reaction mixtures contained 80 μM lysophospholipid, 12.5 μM \[^14^C\]acyl-CoA (55 mCi/mmol), and 50 μg of microsomal protein of *C. elegans* in a total volume of 0.8-ml assay buffer (0.15 M KCl, 0.25 M sucrose, 50 mM potassium phosphate buffer \[pH 6.8\]). After incubation at 20°C for 5 min, reactions were stopped by the addition of 2 ml of methanol. Total lipid was extracted by the method of Bligh and Dyer, and separated by one-dimensional TLC on silica gel 60 plates (Merck) in chloroform/methyl acetate/1-propanol/methanol/0.25% KCl (25/25/25/10/9, vol/vol). To check the positional specificity, the radiolabeled product was reextracted from the TLC plates and treated with bee venom PLA~2~ (Supplementary Figure 2). The distribution of radioactivity between the resultant *sn*-1-acyl lysophospholipid and free fatty acids was assessed after TLC in chloroform/methanol/acetic acid/water (50:30:8:4, vol/vol). Acyl-CoA:*sn*-2-acyl lysophospholipid acyltransferase activity was determined by the radioactivity of *sn*-1-acyl lysophospholipid (Supplementary Figure 2, B and C). Acyl-CoA:*sn*-1-acyl lysoPI acyltransferase assay was performed essentially as described previously ([@B36]), except that 50 μg of microsomal protein and 80 μM lysoPI from bovine liver were used for the acyltransferase assay. Acyltransferase activity of the HEK 293 cell microsomes was measured similarly, except that the incubation temperature was 37°C.

Cell Culture and Transfection
-----------------------------

HEK 293 cells were maintained in Dulbecco\'s modified eagle medium (DMEM) supplemented with 10% fetal calf serum, penicillin (100 U/ml), streptomycin (100 mg/ml), and [l]{.smallcaps}-glutamine (2 mM). Transfection of the plasmid DNA into cells was performed using LipofectAMINE 2000 (Invitrogen, San Diego, CA) according to the manufacturer\'s protocol.

Microscopy and Phenotypic Analysis
----------------------------------

Animals were mounted on a 5% agar pad on a glass slide and immobilized in 0.02 M azide. Fluorescence images were obtained using an Axio Imager M1 (Carl Zeiss MicroImaging, Japan) microscope equipped with a digital CCD camera. Confocal images were obtained using a Zeiss LSM510META confocal microscope system (Carl Zeiss MicroImaging, Thornwood, NY). The orientation of seam cell division was analyzed as previously described ([@B31]). Briefly, a line was drawn between the two daughter nuclei and the angle between this line and the A-P axis was calculated. The angle outside the range of ±10° was defined as abnormal.

Western Blot Analysis
---------------------

Mix-stage populations of worms were collected and sonicated in SET buffer (10 mM Tris-HCl, pH 7.4, 1 mM EDTA, and 250 mM sucrose) with protease inhibitors (5 μg/ml leupeptin, 5 μg/ml pepstatin A, 5 μg/ml aprotinin, and 1 mM PMSF). After sonication, the lysates were centrifuged at 1000 × *g* for 10 min at 4°C. The resulting supernatants were further centrifuged at 100,000 × *g* for 60 min at 4°C, and the supernatant and sedimented fractions (S100 and P100, respectively) were subjected to SDS-PAGE and immunoblotting. The antibodies used in the immunoblots and their dilutions were anti-IPLA-1 polyclonal antibody ([@B31]), 1:20; anti-mCherry mAb (632543, Clontech), 1:1000; anti-α-tubulin mAb (DM1A, Sigma) 1:5000; and anti-green fluorescent protein (GFP) mAb (JL-8, Clontech), 1:1000.

RESULTS
=======

ipla-1 Mutation Causes Reduced Stearic Acid Content of PI
---------------------------------------------------------

PLA~1~ is an enzyme that hydrolyzes fatty acids attached at the *sn*-1 position of phospholipids. The *C. elegans* genome contains one intracellular PLA~1~ family member named *ipla-1* ([@B31]). To determine the role of *ipla-1* in phospholipid metabolism, we first analyzed the fatty acid composition of phospholipids in wild-type and *ipla-1* mutants by GC ([Figure 1](#F1){ref-type="fig"}, A--D). GC analysis of PC, PE, PS, and PI revealed that the *ipla-1* mutation significantly affected the fatty acid composition of PI, but not the fatty acid compositions of PC, PE, or PS. In *ipla-1* mutants, the amount of stearic acid (18:0), which is the major fatty acid in the *sn*-1 position of PI, was reduced to 6.0% of total PI fatty acids compared with 25.1% in wild-type animals. Conversely, the amount of vaccenic acid (18:1n-7) in PI increased to 25.6% of total PI fatty acids compared with 16.0% in wild-type animals. The amount of EPA (20:5), the predominant fatty acid at the *sn*-2 position of PI in *C. elegans* (Supplementary Figure 1; [@B36]) was not affected. Consistent with this observation, LC/ESI-MS analysis revealed that the amount of 18:0/20:5-PI was reduced and instead, 18:1/20:5-PI was increased in *ipla-1* mutants ([Figure 2](#F2){ref-type="fig"}). These data indicate that *ipla-1* is required for the incorporation of 18:0 into the *sn*-1 position of PI.

![Fatty acid composition of PI (A), PC (B), PE (C), and PS (D) from wild-type, *ipla-1* mutants and *acl-8 acl-9 acl-10* triple mutants. GC analysis was used to measure the individual fatty acid species. cyclo, total cyclopropane fatty acids (17: Δ, 19: Δ); branched, branched fatty acids (15:0 iso, 15:0 ante, 16:0 iso, 17:0 iso, 17:0 ante); others, unidentified fatty acids. Bars, mean ± SEM of at least three independent experiments. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001.](zmk0181095800001){#F1}

![MS analysis of PI molecular species. Negative ionization LC/ESI-MS spectra of PI molecular species of wild-type (top), *ipla-1* mutants (middle), and *acl-8 acl-9 acl-10* triple mutants (bottom). Assigning specific molecular species to m/z values was based on their calculated theoretical monoisotopic masses and verified by MS/MS. Lower case a refers to alkyl ether linkage.](zmk0181095800002){#F2}

Fatty Acid Composition of PI in acl-8 acl-9 acl-10 Triple Mutants Is Similar to That in ipla-1 Mutants
------------------------------------------------------------------------------------------------------

Deacylation-reacylation of phospholipids by PLA and acyltransferase is assumed to be important for acquiring the appropriate fatty acid composition of membrane phospholipids ([@B33]; [@B56]; [@B34]). So far, several acyltransferases that incorporate fatty acids into the *sn*-2 position of lysophospholipids have been identified and are classified into two gene families, the 1-acylglycerol-3-phosphate *O*-acyltransferase (AGPAT) family and the MBOAT family ([@B51]). We have isolated all mutants of AGPAT family members in *C. elegans* (*acl-1-14*; Supplementary Table 1) and found that the triple mutants of *acl-8, -9*, and *-10* (Supplementary Figure 3), which are closely related to each other (Supplementary Figure 4), exhibited vulval defects similar to those of *ipla-1* mutants (see below). This observation led us to examine the fatty acid composition of phospholipids in *acl-8 acl-9 acl-10* triple mutants \[*acl-8 acl-9 (tm2290) acl-10 (tm1045)*\].

In *acl-8 acl-9 acl-10* mutants, the amount of stearic acid (18:0) in PI was reduced (25.1% in wild-type vs. 10.0% in *acl-8 acl-9 acl-10* mutants), whereas the amount of vaccenic acid (18:1n-7) in PI increased (16.0% in wild-type vs. 27.5% in *acl-8 acl-9 acl-10* mutants) in a similar manner to *ipla-1* mutants ([Figure 1](#F1){ref-type="fig"}A). The amount of EPA (20:5) in PI was unaltered. LC/ESI-MS analysis showed that 18:0/20:5-PI was replaced by 18:1/20:5-PI in *acl-8 acl-9 acl-10* mutants like it was in *ipla-1* mutants. No drastic changes were observed in the fatty acid compositions of other phospholipids such as PC, PE, and PS ([Figure 1](#F1){ref-type="fig"}, B--D). These data indicate that *acl-8*, *-9*, and *-10* are also involved in the incorporation of 18:0 into the *sn*-1 position of PI.

Phenotypes of acl-8 acl-9 acl-10 Triple Mutants Are Similar to Those of ipla-1 Mutants
--------------------------------------------------------------------------------------

We previously demonstrated that *ipla-1* mutants exhibited defects in vulval morphology (Supplementary Figure 5, A and B) and cell division of lateral epithelial cells, termed seam cells ([Figure 3](#F3){ref-type="fig"} and [Table 1](#T1){ref-type="table"}; [@B31]). In the course of constructing the *acl-8 acl-9 acl-10* triple mutants used above, we noticed that *acl-8 acl-9 acl-10* mutants, like *ipla-1* mutants, showed vulval defects, including protruding and bursting vulvae (Supplementary Figure 5, A--C). To address whether *acl-8 acl-9 acl-10* mutants also show abnormal cell division of seam cells, we analyzed the seam cell divisions of *acl-8 acl-9 acl-10* mutants using a seam cell marker, *scm::gfp*. During the larval stages, seam cells divide asymmetrically in a stem cell-like manner, producing an anterior daughter cell that fuses with a major epithelial syncytium (hyp7) and loses the expression of *scm::gfp*, and a posterior daughter cell that assumes the seam cell fate again and continues to express *scm::gfp* ([Figure 3](#F3){ref-type="fig"}A). Each seam cell division is oriented parallel to the anterior-posterior axis (A-P axis). Because orientation of seam cell division is randomized relative to the A-P axis in *ipla-1* mutants ([@B31]), we first analyzed the orientation of seam cell division. In wild-type worms, all seam cells divided parallel to the A-P axis as judged by *scm::gfp*, which is expressed in the nuclei of both daughter cells just after the division ([Figure 3](#F3){ref-type="fig"}B and [Table 1](#T1){ref-type="table"}). On the other hand, *ipla-1* mutants exhibited aberrant orientation of seam cell divisions as reported previously ([Figure 3](#F3){ref-type="fig"}C and [Table 1](#T1){ref-type="table"}; [@B31]). *acl-8 acl-9 acl-10* triple mutations also caused misorientation of seam cell divisions similar to that observed in *ipla-1* mutants (i.e., the seam cells divided obliquely, and sometimes at right angles to the A-P axis; [Figure 3](#F3){ref-type="fig"}D and [Table 1](#T1){ref-type="table"}). Next, we investigated the cell lineage pattern of seam cells at the L4 stage in *acl-8 acl-9 acl-10* mutants. As mentioned above, in wild-type worms, all posterior daughter cells maintained expression of *scm::gfp* and assumed the seam cell fate again ([Figure 3](#F3){ref-type="fig"}E). In contrast, the seam cell division became symmetric or was reversed (the fates of daughters were the opposite of what they are in the wild type) in *ipla-1* mutants (62%, n = 53; [Figure 3](#F3){ref-type="fig"}F; [@B31]). Similarly, the asymmetry of the divisions was often disrupted in *acl-8 acl-9 acl-10* mutants (67%, n = 25; [Figure 3](#F3){ref-type="fig"}G). These observations indicate that *acl-8 acl-9 acl-10* mutants, like *ipla-1* mutants, are defective in orientation and cell-fate determination of seam cell divisions.

![*ipla-1* mutants and *acl-8 acl-9 acl-10* triple mutants are defective in the orientation and asymmetric cell-fate determination of seam cell divisions. Anterior is toward the left. (A, top) Schematic arrangement of seam cells on each side in an early L1 larva. (A, bottom) The postembryonic division pattern of V seam cells. The expression pattern of *scm::gfp*, which is specifically expressed in the nuclei of seam cells, is indicated by green lines. The box marks the lineages analyzed in this study: V5.pppp lineage (a), V6.papp lineage (b), and V6.pppp lineage (c). Gray circles represent anterior daughters that fuse with the epithelial syncytium, hyp7, and green squares denote seam cells. Red and blue lines indicate the developmental stages corresponding to those of B--D and E--G, respectively. (B--D) Fluorescent images of *scm::gfp* just after the divisions at the L4 stage. The shapes of the worms are indicated by dotted lines. Three pairs of daughter cells are shown with brackets. (B) Wild-type. All seam cells divide parallel to the A-P axis. (C and D) Representative *scm::gfp* images of *ipla-1* mutants (C) and *acl-8 acl-9 acl-10* triple mutants (D). In *ipla-1* mutants and *acl-8 acl-9 acl-10* triple mutants, the seam cell division is randomly oriented relative to the A-P axis (C and D; \*). (E--G) Seam cells at the late L4 stage visualized by *scm::gfp*. Merged fluorescence and differential interference contrast images are shown. The letters (a), (b), and (c) correspond to those of A. (E) Wild-type. The posterior daughter cells adopt the seam cell fate in all the three lineages. (F and G) Representative *scm::gfp* images of *ipla-1* mutants (F) and *acl-8 acl-9 acl-10* triple mutants (G). The asymmetry of the divisions is often disrupted in *ipla-1* mutants and *acl-8 acl-9 acl-10* triple mutants. Scale bars, 20 μm.](zmk0181095800003){#F3}

###### 

Orientation of seam cell division

  Strain                         \% of cell divisions with abnormal orientation   n
  ------------------------------ ------------------------------------------------ -----
  Wild type                      0                                                110
  *ipla-1*                       52.4                                             107
  *acl-8 acl-9*                  0                                                104
  *acl-10*                       43.7                                             112
  *acl-8 acl-9 acl-10*           40.6                                             114
  *ipla-1; acl-8 acl-9 acl-10*   46.7                                             107
  *acl-8 acl-9 acl-10; tbc-3*    5.7                                              141
  *acl-8 acl-9 acl-10; mon-2*    5.5                                              109

In *C. elegans*, the Wnt/β-catenin asymmetry pathway determines the cell fate of most asymmetric divisions ([@B40]). In asymmetric division of seam cells, Wnt is expressed posterior to the mother cell before dividing, and this polarity information is converted to anterior cortical localization of β-catenin WRM-1 ([@B47]; [@B54]; [@B39]). The asymmetrical localization of WRM-1 in the mother cell is ultimately responsible for the asymmetric transcription in the two daughter cells after division of the mother cell. To understand the nature of the defects in the asymmetric division of *acl-8 acl-9 acl-10* mutants, we examined the subcellular localization of WRM-1::GFP in mother seam cells at the L4 stage in *acl-8 acl-9 acl-10* mutants. In wild-type seam cells, punctate fluorescence was clearly visible near the cell membrane in the anterior half of the cells ([Figure 4](#F4){ref-type="fig"}A). On the other hand, the cortical localization of WRM-1::GFP was randomized in *ipla-1* mutants as described previously ([Figure 4](#F4){ref-type="fig"}B; [@B31]). The asymmetric cortical localization of WRM-1::GFP was also disrupted in *acl-8 acl-9 acl-10* mutants, in which the localization of WRM-1::GFP was symmetric or enriched anteriorly or posteriorly in seam cells before divisions, and occasionally, we observed cytoplasmic puncta of WRM-1::GFP similar to those in *ipla-1* mutants ([Figure 4](#F4){ref-type="fig"}, B and C). These results indicate that both *ipla-1* and *acl-8, -9, -10* are required for the formation and/or maintenance of cortical asymmetry of WRM-1 before the divisions of the seam cells.

![Cortical asymmetry of β-catenin WRM-1 is disrupted in *acl-8 acl-9 acl-10* triple mutants similar to that in *ipla-1* mutants. Confocal images showing WRM-1::GFP localization in the V6.pppp cell of wild-type (A), *ipla-1* mutants (B) and *acl-8 acl-9 acl-10* triple mutants (C) before division of the cell. The anterior and dorsal sides of the cells are on the left and bottom, respectively. Scale bars, 5 μm. The shapes of the seam cells are indicated by dotted lines.](zmk0181095800004){#F4}

Suppressor Mutations of ipla-1 Suppress the Seam Cell Defects of acl-8 acl-9 acl-10 Triple Mutants
--------------------------------------------------------------------------------------------------

In a previous genetic screen, we isolated two alleles, *tbc-3(xh23)* and *mon-2(xh22)*, as suppressors of the seam cell defects of *ipla-1* mutants ([@B31]). *mon-2* encodes a homologue of an ARF GEF-like protein and *tbc-3* encodes a homologue of a Rab GAP, both of which have been reported to regulate endosome-to-Golgi retrograde transport ([@B32]; [@B20]). We also found that a seam cell-specific RNAi for the retromer complex, which is also known to control intracellular retrograde transport ([@B50]), suppresses the seam cell phenotypes of *ipla-1* mutants, suggesting that reduction of endosome-to-Golgi retrograde transport in seam cells rescues the seam cell defects of *ipla-1* mutants ([@B31]). In this study, we found that mutation of *tbc-3* did not appreciably change the PI molecular species in *ipla-1* mutants (Supplementary Figure 6), suggesting that the mutation suppresses seam cell phenotypes by abnormal membrane traffic downstream of altered PI molecular species.

To address whether the seam cell defects of *acl-8 acl-9 acl-10* mutants are also mediated by retrograde transport, we crossed *acl-8 acl-9 acl-10* mutants with *tbc-3(xh23)* or *mon-2(xh22)* mutants and analyzed seam cell divisions. The orientation of seam cell divisions was restored in both *acl-8 acl-9 acl-10; tbc-3* and *acl-8 acl-9 acl-10; mon-2* mutants. The percent of the seam cells in which the angle between the A-P axis and the direction of cell division was more than 10° was 6% in the *acl-8 acl-9 acl-10; tbc-3* and *acl-8 acl-9 acl-10; mon-2* mutants, whereas it was 41% in the *acl-8 acl-9 acl-10* mutants ([Figure 5](#F5){ref-type="fig"}, A and B; [Table 1](#T1){ref-type="table"}). The abnormal localization of WRM-1::GFP observed in the mother seam cells of *acl-8 acl-9 acl-10* mutants was also rescued by a mutation of *tbc-3(xh23)* or *mon-2(xh22)* ([Figure 5](#F5){ref-type="fig"}, C and D). These results suggest that the seam cell defects of *ipla-1* mutants and *acl-8 acl-9 acl-10* mutants occur through the same pathway, which is mediated by retrograde transport.

![Seam cell defects of *acl-8 acl-9 acl-10* mutants are suppressed by a mutation of *tbc-3* or *mon-2*. Anterior is oriented toward the left. (A and B) Randomized orientation of seam cell division is suppressed in *acl-8 acl-9 acl-10; tbc-3* mutants (A) and *acl-8 acl-9 acl-10; mon-2* mutants (B). Scale bars, 20 μm. (C and D) Anterior cortical localization of WRM-1::GFP is also restored in *acl-8 acl-9 acl-10; tbc-3* mutants (C) and *acl-8 acl-9 acl-10; mon-2* mutants (D). Scale bars, 5 μm.](zmk0181095800005){#F5}

Recombinant IPLA-1 Hydrolyzes a Fatty Acid Attached to PI
---------------------------------------------------------

Mammals have at least three members of the intracellular PLA~1~ family, namely PA-PLA~1~, KIAA0725, and p125, all of which show significant homology to an *ipla-1* gene product (IPLA-1; [@B23]; [@B46]; [@B31]). PA-PLA~1~ and KIAA0725 have been reported to hydrolyze the *sn*-1 fatty acids attached to PI in in vitro assays ([@B22]; [@B41]). To determine whether *C. elegans* IPLA-1 also has hydrolytic activity toward PI, we prepared recombinant IPLA-1 by expressing it in HEK cells ([Figure 6](#F6){ref-type="fig"}A, see *Materials and Methods*). As shown in [Figure 6](#F6){ref-type="fig"}B, the purified recombinant IPLA-1 showed hydrolytic activity toward PI. PS and PC were also hydrolyzed by IPLA-1, but PE or PA did not serve as a substrate ([Figure 6](#F6){ref-type="fig"}B).

![Enzymatic assay of IPLA-1 and ACL-10. (A) Purification of IPLA-1 expressed in HEK 293 cells was verified by SDS-PAGE followed by Coomassie Brilliant Blue staining. Left, lysates of HEK 293 cells transfected with *ipla-1* cDNA in the pFLAG-CMV2 vector ([@B31]). Right, FLAG-IPLA-1 purified with anti-FLAG M2 affinity gel (Sigma) and eluted with buffer containing the FLAG peptide. (B) Substrate specificity of IPLA-1. The following phospholipids were used for substrates; dioleoyl PA, dioleoyl PC, dioleoyl PE, 1-palmitoyl-2-oleoyl PS, and dipalmitoyl PI. For details of the assay procedure, see *Materials and Methods.* (C) Substrate specificity of ACL-10. Acyltransferase activities of wild-type (□) or ACL-10--expressing transgenic worms (*xhIs3501\[dpy-7p::acl-10\]*; ■) were measured using \[^14^C\]stearoyl-CoA as an acyl donor and the indicated *sn*-2-acyl lysophospholipids as acyl acceptors. Bars, mean ± SEM of at least three independent experiments. \*\*p \< 0.01.](zmk0181095800006){#F6}

ACL-10 Possesses Acyltransferase Activity toward the sn-1 Position of PI
------------------------------------------------------------------------

*acl-10* single mutants showed defects in vulval morphology and seam cell divisions comparable to those of *acl-8 acl-9 acl-10* triple mutants, whereas *acl-8 acl-9* double mutants exhibited no abnormalities in vulval morphology or seam cell divisions ([Table 1](#T1){ref-type="table"} and Supplementary Figure 5, C--E and I--K), indicating that *acl-10* predominantly contributes to vulval morphology and seam cell divisions. We therefore focused on *acl-10* and examined whether an *acl-10* gene product (ACL-10) has LPIAT activity toward the *sn-*1 position of PI. The membrane fraction of ACL-10-expressing transgenic worms (*xhIs3501\[dpy-7p::acl-10\]*; see *Materials and Methods*) showed increased *sn*-2-acyl LPIAT activity with stearoyl-CoA as an acyl donor ([Figure 6](#F6){ref-type="fig"}C). Acyltransferase activities against other *sn-*2-acyl lysophospholipids, such as lysoPC, lysoPE, lysoPS, and lysoPG, did not increase significantly ([Figure 6](#F6){ref-type="fig"}C), indicating that ACL-10 prefers *sn*-2-acyl lysoPI as an acyl acceptor. Increased *sn*-2-acyl LPIAT activity was also observed when we used palmitoyl-CoA (16:0-CoA) and oleoyl-CoA (18:1n-9-CoA), but not arachidonoyl-CoA (20:4n-6-CoA), as acyl donors (data not shown). These data indicate that ACL-10 has acyltransferase activity toward the *sn-*1 position of PI with a preference for saturated and mono-unsaturated fatty acids. In the membrane fraction of *acl-8 acl-9 acl-10* mutants, *sn*-2-acyl LPIAT activity was significantly reduced when we used stearoyl-CoA (18:0-CoA) as the acyl donor (Supplementary Figure 7). However, it was not reduced when we used arachidonoyl-CoA (20:4n-6-CoA), which is the preferred acyl donor of MBOA-7/LPIAT. This result indicates that ACL-8, -9, and -10 contribute to *sn*-2-acyl LPIAT activity with stearoyl-CoA, but not with arachidonoyl-CoA, in *C. elegans*. The observation that appreciable activity was still detected in the membrane fraction of *acl-8 acl-9 acl-10* mutants suggests the existence of other *sn*-2-acyl LPIAT in the worms.

IPLA-1 and ACL-10 Are Expressed in the Endoplasmic Reticulum of Epithelial Cells
--------------------------------------------------------------------------------

We also examined the expression pattern of *acl-10* by using a transcriptional GFP fusion gene. Strong *acl-10p*::GFP expression was observed in seam cells throughout development ([Figure 7](#F7){ref-type="fig"}A). Expression of GFP was also observed in other epithelial cells, such as vulval epithelial cells and the major epithelial syncytium hyp7, and in several head neurons including AIY interneurons ([Figure 7](#F7){ref-type="fig"}, B and C). To analyze the intracellular localizations of IPLA-1 and ACL-10, we generated a transgenic strain expressing IPLA-1::mCherry and ACL-10::GFP under the control of the epidermal-specific *dpy-7* promoter and *acl-10* own promoter, respectively. IPLA-1::mCherry and ACL-10::GFP rescued the phenotypes of *ipla-1* mutants and *acl-8 acl-9 acl-10* mutants, respectively (Supplementary Figure 5, F and G), indicating that these fusion proteins are functional. As shown in [Figure 7](#F7){ref-type="fig"}D, IPLA-1::mCherry and ACL-10::GFP were distributed in an endoplasmic reticulum (ER)-like reticular pattern throughout the cytoplasm and were partially colocalized. We also found that both IPLA-1 and ACL-10 partially colocalized with an ER marker, ACS-20::EGFP (Supplementary Figure 8; [@B30]). Furthermore, an immunoblot analysis revealed that both IPLA-1 and ACL-10 were present in the membrane fraction ([Figure 7](#F7){ref-type="fig"}E). IPLA-1 was also present in the soluble fraction ([Figure 7](#F7){ref-type="fig"}E), as was its mammalian homologue, KIAA0725 ([@B46]; [@B42]). These data indicate that ACL-10 and a portion of IPLA-1 are localized at the ER membrane in epithelial cells.

![Expression of *ipla-1* and *acl-10*. (A--C) Confocal images of transgenic worms expressing *acl-10p::GFP.* Seam cells (A--C: arrowheads), epithelial syncytium hyp7 (A: bracket), vulval epithelium (B: arrows), and several neurons including AIYL/R (C: arrowheads) in the head region at the adult stage. Scale bars, 40 μm. (D) Confocal images of epithelial cells of a transgenic L4 worm expressing IPLA-1::mCherry and ACL-10::GFP. Bar, 20 μm. (E) Subcellular fractionation of IPLA-1 and ACL-10. Lysate of transgenic worms expressing ACL-10::mCherry and ACS-20::EGFP (*acs-20;acs-22;xhEx3529\[acl-10p::acl-10::mCherry\]; tmEx1920\[acs-20p::acs-20::egfp\]*) were subjected to S100 (cytosol)/P100 (membrane) fractionation and processed for immunoblotting with anti-IPLA, anti-mCherry (ACL-10), anti-α-tubulin (cytoplasmic marker), and anti-GFP (ER marker ACS-20) antibodies. *acs-20* encodes a very long chain fatty acid acyl-CoA synthetase that is known to be localized in ER membranes. *acs-22* is a homologous gene of *acs-20. acs-20p::acs-20::egfp* transgene fully rescues the phenotypes of *acs-20;acs-22* double mutants ([@B30]).](zmk0181095800007){#F7}

DISCUSSION
==========

Identification of ipla-1 and acl-8, -9, -10 as Strong Candidates for Enzymes Involved in Fatty Acid Remodeling at the sn-1 Position of PI
-----------------------------------------------------------------------------------------------------------------------------------------

PI is a membrane phospholipid that has a unique fatty acid composition in that 1-stearoyl-2-arachidonoyl species is predominant in mammals ([@B25]; [@B3]). *C. elegans*, in which EPA is a major PUFA in membrane phospholipids and AA is a minor component, possesses 1-stearoyl-2-eicosapentaenoyl PI as the major molecular species ([@B36]). These molecular species are thought to be formed by a fatty acid remodeling reaction after the de novo synthesis of PI ([@B24]; [@B45]; [@B13],[@B14]). The remodeling reaction involves the hydrolysis of a fatty acyl ester bond at the *sn*-1 or -2 position of the newly synthesized phospholipids and subsequent incorporation of the appropriate fatty acid into the position. We recently identified the acyltransferase, named *mboa-7*/LPIAT, which preferentially incorporates AA and EPA into the *sn-*2 position of PI ([@B36]). In the present study, we identified PLA~1~ (*ipla-1*) and acyltransferases (*acl-8, -9, -10*) that are involved in the incorporation of stearic acid into the *sn-*1 position of PI. We demonstrated that 1) stearic acid (18:0) attached at the *sn*-1 position of PI is replaced with vaccenic acid (18:1n-7) in both *ipla-1* mutants and *acl-8 acl-9 acl-10* mutants, 2) *ipla-1* mutants and *acl-8 acl-9 acl-10* mutants show similar phenotypes (i.e., they exhibit defects in orientation of seam cell divisions, cell-fate determination of seam cells, and cortical localization of β-catenin in mother seam cells), and 3) these phenotypes are suppressed by a same mutation (*tbc-3(xh23)* or *mon-2(xh22)*) in both *ipla-1* mutants and *acl-8 acl-9 acl-10* mutants. Together, these data strongly suggest that *ipla-1* (PLA~1~) and *acl-8*, *-9*, *-10* (acyltransferases) function in the same pathway. We also showed that *ipla-1* mutants, *acl-8 acl-9 acl-10* mutants, and *ipla-1; acl-8 acl-9 acl-10* quadruple mutants have seam cell defects with similar penetrance ([Table 1](#T1){ref-type="table"}) and have similar fatty acid compositions of PI (Supplementary Figure 9), indicating no synergism between the *ipla-1* and *acl-8 acl-9 acl-10* mutations. These data further support the idea that *ipla-1* and *acl-8*, *-9*, *-10* function in the same pathway. In in vitro analyses, IPLA-1 was capable of hydrolyzing the fatty acyl moiety of PI, and ACL-10 transferred stearic acid to the *sn-*1 position of PI. From these observations, we propose that *ipla-1* functions as a PLA~1~ and that *acl-8*, *-9*, *-10* function as acyltransferases in the fatty acid remodeling of the *sn-*1 position of PI (Supplementary Figure 10).

Calcium-independent PLA~2~ (iPLA~2~) has been assumed to play a role in fatty acid remodeling of the *sn-*2 position of phospholipids ([@B4]). Recent knockout studies, however, revealed that lack of iPLA~2~β causes no significant change in the fatty acid composition of membrane phospholipids ([@B6]). Knockout mice of iPLA~2~γ, which hydrolyze the *sn-*2 ester bond of PC, show marked differences in fatty acid composition of cardiolipin ([@B38]), although the mechanism by which the fatty acid composition of cardiolipin is changed is unclear. As for PLA~1~, three members of the intracellular PLA~1~ family (PA-PLA1, KIAA0725, and p125) have been identified and analyzed ([@B29]; [@B42]), although the contribution of these PLA~1~s to fatty acid composition of membrane phospholipids is unknown. The present results show that *ipla-1* mutants, in which PI-recognizing PLA~1~ is disrupted, have altered fatty acid composition of PI and seam cell defects similar to those observed in the *acl-8 acl-9 acl-10* mutants, which lack acyltransferases for transferring the fatty acid at the *sn-*1 position of PI. To our knowledge, *ipla-1* is the first identified phospholipase involved in the fatty acid remodeling at the *sn*-1 position of membrane phospholipids. In an in vitro analysis, IPLA-1 also showed hydrolytic activity toward PS and PC in addition to PI ([Figure 6](#F6){ref-type="fig"}B), although the *ipla-1* mutation did not appreciably affect the fatty acid composition of PS and PC in vivo ([Figure 1](#F1){ref-type="fig"}). It is possible that IPLA-1 cleaves the *sn*-1 fatty acyl bond of PS and PC under our in vitro condition, but not in vivo. Alternatively, lysoPS and lysoPC produced by IPLA-1 might be reacylated back to their original states by certain acyltransferases in vivo.

According to the model shown in Supplementary Figure 10, mutations of *acl-8*, *-9*, *-10* are expected to accumulate lysoPI, but not to accumulate 18:1/20:5-PI. However, in *acl-8 acl-9 acl-10* mutants, the amount of 18:1/20:5-PI increased ([Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}), and lysoPI was not detected by our measuring system (data not shown). This may be because acyltransferases other than ACL-8, -9, -10 transfer 18:1, the principal fatty acid in *C. elegans* ([@B28]), to the *sn-*1 position of PI in *acl-8 acl-9 acl-10* mutants. It is also possible that IPLA-1 and ACL-8, -9, -10 activities are coupled so that IPLA-1 is inactive when ACL-8, -9, -10 are lost.

As mentioned above, *acl-10* single mutants showed seam cell defects comparable to those of *acl-8 acl-9 acl-10* triple mutants, whereas *acl-8 acl-9* double mutants exhibited no abnormalities ([Table 1](#T1){ref-type="table"}), indicating that *acl-10* predominantly contributes to seam cell divisions. In *acl-10* single mutants, the amount of 18:0/20:5-PI was reduced and the amount of 18:1/20:5-PI was increased compared with the amounts in wild-type worms. However, the changes were less than those observed in *acl-8 acl-9 acl-10* mutants (Supplementary Figure 11A). As shown in [Figure 7](#F7){ref-type="fig"}A, *acl-10* is strongly expressed in seam cells, but is not expressed in intestinal cells or muscle cells, which form large organs in *C. elegans*. We also found that *acl-10* mRNA obtained from the whole *C. elegans* body was less than that of *acl-8* or *-9* as judged by quantitative real-time PCR (Supplementary Figure 11B). Therefore, the local expression of *acl-10* appears to be the cause of the weak change of PI molecular species in *acl-10* single mutants.

Several laboratories, including ours, have identified acyltransferases that incorporate fatty acids into the *sn*-2 position of lysophospholipids ([@B51]). However, the acyltransferases transferring fatty acids at the *sn*-1 position of lysophospholipids are largely unknown. Very recently, another acyltransferase, Psi1p, was shown to catalyze acyl transfer to the *sn*-1 position of PI in yeast ([@B35]). In *psi1* Δ mutants, the content of stearic acid at the *sn*-1 position of PI is reduced, but the physiological function of Psi1p has not been elucidated. We show here that the *C. elegans* acyltransferase toward the *sn*-1 position of PI is required for asymmetric cell division, the fundamental mechanism by which multicellular organisms generate cell diversity.

Asymmetric Cell Division and Fatty Acid Remodeling of PI
--------------------------------------------------------

The present results demonstrate that both *ipla-1* mutants and *acl-8 acl-9 acl-10* mutants have defects in asymmetric cell divisions of stem-cell like epithelial cells, named seam cells. In *C. elegans*, the Wnt/β-catenin asymmetry pathway determines the cell fate of most asymmetric divisions ([@B40]; i.e., Wnt expressed posterior to the mother cell induces anterior cortical localization of β-catenin in the mother cell, leading to asymmetric cell-fate determination between the two daughter cells). Both *ipla-1* mutants and *acl-8 acl-9 acl-10* mutants exhibit defects in anterior cortical localization of β-catenin in mother cells and cell-fate determination of the daughter cells. We also found that *ipla-1* and *acl-10* act cell-autonomously to regulate asymmetric cell divisions of seam cells ([@B31] and Supplementary Figure 5L, respectively). These data suggest that in *ipla-1* mutants and *acl-8 acl-9 acl-10* mutants, the altered fatty acid composition of PI in mother cells causes abnormal intracellular distribution of β-catenin, leading to defects in cell-fate determination of the daughter cells.

How is the fatty acid composition of PI involved in asymmetric cell divisions? It has been reported that asymmetric cortical enrichment of a phosphoinositide synthesis enzyme, *ppk-1* \[PI(4)P5-kinase\], is required for asymmetric cell division in the one-celled *C. elegans* embryo ([@B48]). We also found that seam cell-specific knockdown of *ppk-1* results in defective asymmetric division of seam cells (our unpublished data). These data suggest that the cortical asymmetry of phosphoinositides is important for asymmetric cell divisions. Furthermore, a recent study revealed that in HeLa cells, PI(3,4,5)P3 is accumulated in the midsection at the cortex, and the cortical localization of PI(3,4,5)P3 plays a crucial role in the orientation of cell divisions ([@B55]). These previous reports, together with our findings, suggest that the cortical localization of phosphoinositides in the mother cell is required for correctly determining the fates of the two daughter cells and for the correct orientation of the cell divisions.

It has been assumed that cell-fate determination and orientation of the two daughter cells require the polarized distribution of cortical proteins in the mother cell ([@B21]; [@B52]) and that the polarized distribution of cortical proteins is achieved by membrane trafficking ([@B7]; [@B49]). Meanwhile, it has been shown that differences in acyl chains in membrane phospholipids are responsible for the differential lateral distribution and accumulation of lipids in membrane microdomains (i.e., the phospholipids with long and saturated acyl chains preferentially partition into more rigid or highly ordered domains, such as lipid rafts, while those with short or unsaturated tails prefer to enter more fluid regions of the bilayer; [@B43]). We speculate that in the mother seam cells of *ipla-1* mutants and *acl-8 acl-9 acl-10* mutants, the altered fatty acid composition of PI causes abnormal localization of phosphoinositides in the membrane bilayer, leading to the missorting of cortical proteins by retrograde membrane trafficking regulated by *tbc-3* and *mon-2*.

acl-8, acl-9, acl-10 Subfamily Genes Are Evolutionarily Conserved from C. elegans to Mammals
--------------------------------------------------------------------------------------------

In this study, we showed that *acl-8 acl-9 acl-10* mutants have defects in asymmetric division of stem cell-like epithelial cells. *acl-8, -9*, and *-10* form a subfamily of the *C. elegans acl*/AGPAT family and are the closest homologues of LYCAT/ALCAT1, which is conserved in various species including *C. elegans*, zebrafish, chicken, and human (Supplementary Figure 4). So far, mammalian LYCATs have been reported to possess acyltransferase activity toward the *sn*-2 position of anionic lysophospholipids including lysoPI in vitro ([@B10], [@B11]; [@B1]; [@B60]). We revealed that mouse LYCAT transfers stearic acid to the *sn*-1 position of PI as well as the *sn*-2 position of PI at comparable levels (Supplementary Figure 12). Furthermore, we found that expression of mouse LYCAT rescues the defects in asymmetric division in *acl-8 acl-9 acl-10* mutants (Supplementary Figure 5M), indicating that mouse LYCAT is a functional homologue of *acl-8, -9*, and *-10*. Interestingly, mouse LYCAT was reported to be highly expressed in hematopoietic stem cells ([@B57]), which undergo asymmetric divisions to renew themselves and produce the various progeny cells of the distinct blood lineages ([@B12]; [@B19]). In addition, morpholino-mediated knockdown of zebrafish LYCAT results in a reduction of blood cells ([@B59]). Further studies are expected to reveal an evolutionarily conserved role of the *sn*-1 fatty acid of PI in the asymmetric division of stem cells.
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